CA936471A - Process for the manufacture of a vaccine - Google Patents

Process for the manufacture of a vaccine

Info

Publication number
CA936471A
CA936471A CA062932A CA62932A CA936471A CA 936471 A CA936471 A CA 936471A CA 062932 A CA062932 A CA 062932A CA 62932 A CA62932 A CA 62932A CA 936471 A CA936471 A CA 936471A
Authority
CA
Canada
Prior art keywords
vaccine
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA062932A
Other languages
English (en)
Inventor
Jachertz Diether
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA936471A publication Critical patent/CA936471A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA062932A 1968-09-25 1969-09-24 Process for the manufacture of a vaccine Expired CA936471A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681792609 DE1792609A1 (de) 1968-09-25 1968-09-25 Verfahren zur Herstellung einer Vaccine

Publications (1)

Publication Number Publication Date
CA936471A true CA936471A (en) 1973-11-06

Family

ID=5707478

Family Applications (1)

Application Number Title Priority Date Filing Date
CA062932A Expired CA936471A (en) 1968-09-25 1969-09-24 Process for the manufacture of a vaccine

Country Status (16)

Country Link
JP (1) JPS505257B1 (de)
AT (1) AT292195B (de)
BE (1) BE739379A (de)
BR (1) BR6912716D0 (de)
CA (1) CA936471A (de)
CH (1) CH517179A (de)
DE (1) DE1792609A1 (de)
DK (1) DK123944B (de)
ES (1) ES371843A1 (de)
FI (1) FI48105C (de)
FR (1) FR2024779B1 (de)
GB (1) GB1284756A (de)
IE (1) IE33322B1 (de)
IL (1) IL33042A (de)
NL (1) NL6914553A (de)
NO (1) NO127200B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3115559A1 (de) * 1981-04-16 1982-10-28 Kommanditgesellschaft Schwarzhaupt, 5000 Köln Hochgereinigte informatorische ribonukleinsaeure (i-rns), verfahren zur herstellung und verwendung derselben

Also Published As

Publication number Publication date
FI48105C (fi) 1974-06-10
NO127200B (de) 1973-05-21
IE33322L (en) 1970-03-25
JPS505257B1 (de) 1975-03-01
BR6912716D0 (pt) 1973-02-08
IE33322B1 (en) 1974-05-15
NL6914553A (de) 1970-03-31
FI48105B (de) 1974-02-28
ES371843A1 (es) 1972-04-16
IL33042A (en) 1974-01-14
DK123944B (da) 1972-08-21
IL33042A0 (en) 1969-11-30
DE1792609A1 (de) 1972-01-20
AT292195B (de) 1971-08-10
CH517179A (de) 1971-12-31
BE739379A (de) 1970-03-25
FR2024779A1 (de) 1970-09-04
FR2024779B1 (de) 1973-08-10
GB1284756A (en) 1972-08-09

Similar Documents

Publication Publication Date Title
CA931690A (en) Process for the production of trans-polypentenamers
CA918669A (en) Process for the preparation of benzindenes
AU455685B2 (en) A process for the preparation of 6-meethyl-19-nor-pregnenes
CA936471A (en) Process for the manufacture of a vaccine
CA973872A (en) Process for the manufacture of a pyroglutamylpeptide
IL33463A0 (en) A process for the preparation of symmetrical diaryl-disulphides
CA798320A (en) Process for the manufacture of oxytocin
CA787918A (en) Process for the manufacture of a polypeptide
CA928298A (en) Process for the preparation of 3-alkylflavanones
CA787931A (en) Process for the production of o-hydroxyphenyl-s-triazines
CA947298A (en) Process for the production of (-)-norscopolamine
CA796291A (en) Process for the production of a rabies vaccine
AU443811B2 (en) Process forthe manufacture ofa vaccine
CA795311A (en) Process for the manufacture of b-nor- or b-nor-19-nor-androstanes
CA786240A (en) Process for the manufacture of magnesium-ammonium phosphate-hexahydrate
CA799490A (en) Process for the manufacture of aminoisoxazoles
CA793313A (en) Process for the manufacture of 1-glycosyl-5-azacytosines
CA793308A (en) Process for the manufacture of 3-amino-cholestanes
CA790044A (en) Process for the manufacture of a decapeptide
CA788450A (en) Process for the manufacture of a decapeptide
AU403513B2 (en) A process for the preparation of polyalkylcyclohexenes
AU288785B2 (en) A process for the preparation of alpha-methyl-gamma-butyrolactone
CA802926A (en) Process for the preparation of phenyltrichloroacetoimidochlorides
CA791124A (en) Process for the preparation of 21-halonorethisterones
AU447701B2 (en) Process for the preparation of n-tritylimidazoles